Better healthcare
Our products
Grow your brand with our healthcare solutions – making pharmaceuticals more affordable, more available, and better than before.
Our products
High quality affordable, value added, and innovative medicines for global markets
Gain access to novel products , speed up time-to-market and open up unexplored business avenues. We are developing high-quality pharmaceuticals with a patients-centered approach adapted for each market worldwide.
We provide over 180+ products across various therapeutic categories in 10+ dosage forms including highly potent drugs. Value added medicines (VAM) and innovative formulations form an important part of our portfolio.
For more information about our differentiated and innovative product pipeline, please contact us – by filling out the contact form below on this webpage, or please send an email to info@tiefenbacher.com. We are looking forward to sharing out-licensing opportunities based on a CDA.
Disease Areas
Oncology
Respiratory
Neuroscience
Cardiovascular, Renal and Metabolism
Immunology, Hepatology and Dermatology
Infectious Diseases
Ophthalmology
Dosage Forms
Tablets
Capsules
Powders
Drops
Inhalers
Transdermal Patches
Eye Drops
Additional
Medical Devices
CREATING BETTER THERAPIES THROUGH PRODUCT DIFFERENTIATION AND INNOVATION
Value added and innovative medicines which will set you apart
Product differentiation and innovation are a core business at Tiefenbacher Pharmaceuticals. We believe that there are always new ways of smart medicines which better deliver on patients` needs. This includes less side effects, a better API absorption, additional product strengths, new fix-dose combinations, or a personalized dosing with an innovative drug device – just to name a few examples of our distinctive product features and innovations. We are constantly developing new product solutions for reaching an unique selling proposition in the market and bringing added value to patients – always with a patient-centric approach.
Value Added Products
- Once-daily products for better posology
- More patient-friendly dosage forms than the innovator
- Prodrugs with better side-effect profile (e.g. to make MS therapy safer)
- Prodrug with 5 years of IP advantage
- Extended-release formulations with less side effects
- New suitable dosage strengths for better treatment options
- Fix-dose combinations
Innovative Products
- Digital platform for new drug /device combination for personalized treatment
- New orphan indication for known molecule
- New OTC products
- First NCE-approved drug in Europe